New hope for kids with rare muscle cancer: personalized proton therapy and chemo

NCT ID NCT01871766

First seen Nov 01, 2025 · Last updated May 10, 2026 · Updated 29 times

Summary

This study is for children newly diagnosed with rhabdomyosarcoma, a rare muscle cancer. It uses a personalized approach with proton beam radiation, surgery, and standard or stronger chemotherapy based on the child's risk level. Children with higher-risk cancer also receive extra maintenance therapy to help keep the cancer from coming back. The goal is to improve survival while reducing side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RHABDOMYOSARCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Cook Children's Medical Center

    Fort Worth, Texas, 76104, United States

  • Nemours Children's Clinic

    Jacksonville, Florida, 32207, United States

  • St. Jude Children's Research Hospital

    Memphis, Tennessee, 38105, United States

  • University of Florida Proton Therapy Institute

    Jacksonville, Florida, 32206, United States

Conditions

Explore the condition pages connected to this study.